Literature DB >> 23753650

Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.

Michele Nicolo1, Kathleen W Stratton, Wanda Rooney, Joseph Boullata.   

Abstract

Administration of pancreatic enzymes (pancrelipase) to adult patients with cystic fibrosis when receiving enteral nutrition through a feeding tube is challenging. A number of techniques for preparing and administering the drug may result in complications that include feeding tube occlusion and inadequate enzyme delivery to the patient. A series of inpatient encounters is described.

Entities:  

Keywords:  cystic fibrosis; enteral nutrition; enzymes; food-drug interactions; pancreas

Mesh:

Substances:

Year:  2013        PMID: 23753650     DOI: 10.1177/0884533613491786

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  3 in total

1.  Significant Published Articles for Pharmacy Nutrition Support Practice in 2014 and 2015.

Authors:  Roland N Dickerson; Vanessa J Kumpf; Allison B Blackmer; Angela L Bingham; Anne M Tucker; Joseph V Ybarra; Michael D Kraft; Todd W Canada
Journal:  Hosp Pharm       Date:  2016-07

Review 2.  Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.

Authors:  Tony Trang; Johanna Chan; David Y Graham
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

3.  Optimizing Clinical and Cost Outcomes for Patients on Enteral Nutrition Support for Treatment of Exocrine Pancreatic Insufficiency: Proceedings from an Expert Advisory Board Meeting.

Authors:  Joseph I Boullata; Janice L Clarke; Archie Stone; Alexis Skoufalos; David B Nash
Journal:  Popul Health Manag       Date:  2019-06       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.